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Bilateral adrenal hemorrhage is a rare but potentially catastrophic complication of chemoprophylaxis.
We report a patient who underwent a total knee arthroplasty and subsequently developed bilateral
adrenal hemorrhage from enoxaparin. Once the patient was diagnosed with acute adrenal insufﬁciency,
corticosteroids were promptly started, and the patient made a dramatic recovery and did not suffer
further complications.
Copyright © 2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Deep venous thrombosis (DVT) is a known complication of total
joint replacement surgery and,without appropriate anticoagulation
prophylaxis, the prevalence of DVT is reported to be 40e80% in total
knee replacements, 50e60% in total hip replacements, and 30e60%
after hip fracture [1,2]. The associated risk of pulmonary embolism
is approximately 10% with an overall fatality rate of 5% [1,2]. Several
anticoagulation prophylaxis modalities, including pharmacological
and mechanical methods, have been designed to prevent this
complication. However, pharmacological agents, such as unfrac-
tionated heparin, warfarin, low-molecular-weight-heparin, or
rivaroxaban, are not without risks [3]. Development of hematoma,
persistent hemorrhage, and wound complications are among the
commonly reported pharmacophylaxis-related complications [3,4].
Acute bilateral adrenalhemorrhage (BAH), although rare, hasbeen
reported as a potentially catastrophic complication of anticoagulationclosed potential or pertinent
ent, either direct or indirect,
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d/4.0/).therapy [1,5e7]. However, this condition also occurs in the settings of
post-operative period, septicemia, pregnancy, anti-phospholipid
syndrome, heparin-associated thrombocytopenia, trauma, and coa-
gulopathies [1,5e7].
BAH presents a diagnostic challenge to treating physicians due
to non-speciﬁc complaints and symptoms that range from vague
abdominal pain, nausea, vomiting, neuropsychiatric symptoms,
hypotension or shock, and fever [5e7].
To our knowledge, several case reports of BAH from warfarin
and unfractionated heparin exist in a subset of orthopedic patients
undergoing joint replacement surgeries [1,5e20]. However, this is
the ﬁrst reported case of enoxaparin-induced BAH following
arthroplasty. We report a case of BAH secondary to enoxaparin use
after unilateral knee replacement surgery.Case history
A 65 year-old female with end-stage osteoarthritis of the right
knee had progressively worsening joint pain that was refractory to
all non-operative measures. The patient's medical comorbidities
included well-controlled hypertension, gastroesophageal reﬂux
disease, and remote history of DVT. Once the patient failed non-
operative management of her osteoarthritis, the patient was rec-
ommended to undergo right total knee arthroplasty. The risks and
the beneﬁts of the surgery were explained, and informed consent
was obtained. The patient's perioperative and post-operativen of Hip and Knee Surgeons. This is an open access article under the CC BY-NC-ND
Figure 1. Axial CT image demonstrating bilateral adrenal gland enlargements and
diffuse hemorrhage (arrows).
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operative day (POD) two. The patient was placed on enoxaparin
(30 mg B.I.D) for DVT prophylaxis on POD one and was discharged
home with the same regimen for an additional ten days.
On POD eight, the patient was admitted with complaints of
vague epigastric pain, lethargy, and febrile episodes. Symptoms
included decreased appetite, somnolence, anxiety, and nausea
without vomiting. Physical examination was unremarkable, and
vital signs included temperature 101.7 F, heart rate 111, respiration
20, blood pressure 123/87, and oxygen saturation 92% at admis-
sion. Laboratory values showed signiﬁcant hyponatremia (126),Table 1
Characteristics of total arthroplasty patients who suffered bilateral adrenal hemorrhages
Author Age Sex Procedure Post op
days
Dvt prophylaxis Outcome





52 M B/L TKA 9 Enoxaparin dc home
Barrou et al. [8] 80 M TKA 6 Enoxaparin DC home
Best et al. [9] 75 F THA 9 Dabigatran Unknown
Bleasel et al. [10] 69 F TKA rev Unknown SQ heparin Unknown
Chow et al. [11] 44 M B/L TKA 10 Heparin drip DC home
Cozzolino et al. [12] 66 F TKA 7 Coumadin DC home
Delhumeau et al. [13] 74 M THA 4 SQ heparin Unknown
Ernest et al. [14] 68 F THA Unknown SQ heparin Unknown
Hardwicke et al. [15] 63 F B/L TKA 7 SQ heparin
and warfarin
DC home
Kurtz et al. [16] 54 F THA Unknown SQ dalteparin Alive
Mongardon et al. [17] 64 M THA 7 SQ heparin Alive
Schuchmann et al. [19] 83 F B/L TKA 5 SQ heparin Death
Souied et al. [20] 63 F THA 10 SQ heparin Death
Ries, Guiney et al. [21] 61 M B/L TKA 9 Warfarin Death
Park et al.* 65 F TKA 8 Enoxaparin DC home
*Our patient described in the case report.hypokalemia (2.6), glucose (60), hematocrit (25.3), creatinine (0.8),
WBC count (14,900), and platelet count (161,000). The patient was
immediately evaluated, and the differential diagnosis included
pulmonary embolism, sepsis, metabolic encephalopathy, and ad-
renal insufﬁciency.
However, the patient's chest CT scan was negative for pulmo-
nary embolism, and the MRI of the brain was negative for acute
pathology. The medicine teamwas concerned for presumed sepsis,
and empirical intravenous antibiotics (ceftriaxone, vancomycin,
and acyclovir) were promptly started, and various cultures
including CSF, urine, and blood were obtained.
The patient deteriorated rapidly and was transferred to the
intensive care unit and received aggressive intravenous volume
support with pressors. Subsequent clinical and laboratory ﬁndings
suggested possible adrenal insufﬁciency. Basal cortisol levels were
obtained before and after cosyntropin (ACTH) stimulation, and both
values were 0.3 nmol/L. Abdominal CT revealed bilateral adrenal
hemorrhages (Fig. 1). Enoxaparin was immediately discontinued,
and the patient was started on high dose hydrocortisone. The pa-
tient improved dramatically and subsequently left the intensive
care unit within 24e48 h of glucocorticoid administration. Gluco-
corticoid was tapered, and the patient improved clinically and was
discharged without further complications.
The patient most recently followed up with the senior author
at her 1-year visit, and her knee has excellent range of motion, and
X-rays demonstrate well-placed components with no evidence of
loosening. She has since returned to her previous activity level
including bowling.(BAH).
Complaints Initial labs Imaging HIT Tx












Na 129, K 5.5 CT No Corticosteroids
Sob, fever, ab pain Unknown CT Unk Unknown
Fever, nausea, vomiting,
abdominal pain
Unknown None Yes Unknown
Abdominal pain,
tachycardia, fever



















Na 127, K 4.6 CT Unk Dexamthasone
Fever, abdominal pain,
anorexia





Normal labs CT Yes Corticosteroids
Anxious, sob, shock,
fever










Unknown None Unk None
Abdominal pain, nausea,
fever, hypotension
Na 126, K 2.6,
Hct 25.3
CT No Corticosteroids
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Multiple guidelines exist in order to assist physicians with
clinical decisions regarding DVT prophylaxis for elective joint
replacement surgery patients [3,11]. While both mechanical and
pharmacological methods are effective, chemoprophylaxis remains
a popular choice due to its higher compliance rate and ease of use
[3,11]. However, chemoprophylaxis is associated with increased
risk of bleeding, wound complications, and heparin-induced
thrombocytopenia [3,4,6,11,17]. BAH is a rare complication of
chemoprophylaxis. While spontaneous adrenal hemorrhage has
been reported, BAH has been reported in settings of sepsis, trauma,
intra-operative/post-operative complications, severe burns, anti-
coagulant therapy, other coagulopathies [6,7,17].
Following a detailed literature search for BAH cases in hip and
knee arthroplasty patients, a total of 16 cases were identiﬁed
(Table 1). The mean age was 66.5. Six patients (37.5%) underwent
bilateral total knee replacements, and one patient underwent
revision total knee arthroplasty. Clinical symptoms and signs are
summarized in Table 2. Some patients presented with laboratory
abnormalities, such as, hyponatremia (8 patients) and hypokalemia
(2). Acute anemia was present in two patients, and thrombocyto-
penia was present in seven patients. BAH was determined at the
time of autopsy in two cases.
In seven cases, heparin-induced-thrombocytopenia was iden-
tiﬁed as the cause of BAH after conﬁrmatory HIT antibody tests,
however, in three cases (including our case), the HIT antibody test
was negative. In our patient, platelet count was 161,000 at initial
presentation, and remained between 200,000 and 250,000 during
hospitalization. Abdominal CT scans revealed BAH in 12 of 16 pa-
tients, and it was the most reliable diagnostic test. In 10 of 16 pa-
tients, acute adrenal insufﬁciency was further conﬁrmed by a
cosyntropin stimulation test, and these patients received cortico-
steroids and made remarkable recovery within 24e48 h.
BAH often presents with non-speciﬁc signs and symptoms, and
clinical associations are commonlyunrecognized,makingprospective
diagnosis and early treatment exceedingly difﬁcult. Physical exami-
nations are rarely diagnostic, with fever and abdominal pain being
two consistent clinical features [5,18,19]. Laboratory clues include
unexplained drop in hematocrit, leukocytosis, eosinophilia, hypo-
natremia, hyperkalemia, and hypoglycemia [1,5e8,11,12,19,20,23].
While the biochemical evidence of adrenal insufﬁciency including
hyponatremia and hyperkalemia with volume contraction can pro-
vide diagnostic clues for acute adrenal insufﬁciency, not all patients
presented with such laboratory abnormalities. Only 8 of 16 patients
presented with hyponatremia, two patients had hypokalemia only,
and no patient had hyperkalemia at the time of presentation.
CT, MRI and U/S are recommended diagnostic BAH imaging
modalities [19]. Diagnosis is made on abdominal CT or MRI with
common characteristics featuring bilateral rounded adrenal gland
enlargement, conﬁrmed by cosyntropin stimulation. The mass seen
on CT and MRI of adrenal gland with no enhancement or
enhancement only in a pattern of a thin peripheral rim can be used
to distinguish hematoma from other pathologies [12,21].Table 2
Clinical signs and symptoms of the patients from reported BAH cases.
Symptoms Number of patients
Nausea 8/16 (50%)
Abdominal pain 16/16 (100%)
Emesis 3/16 (19%)
Febrile 12/16 (75%)
Confusion/neuropsychiatric symptoms 5/16 (31%)
Hypotension/Shock 9/16 (56%)
Shortness of breath 2/16 (13%)When suspicious for acute adrenal insufﬁciency, cosyntropin
stimulation should be performed to measure the adrenal gland
response to a cosyntropin challenge at 30 and 60 min intervals. A
normal, appropriate response is approximately a two-fold increase in
serum cortisol levels after cosyntropin administration [5,6,18]. With
steroid administration, the dramatic improvement in the cardiovas-
cular status was usually seen, and all patients who received the
corticosteroid therapy made remarkable recovery within 24e48 h of
administration [7,18,22]. However, the clinical course of this disease
does not always follow a favorable one, and, once the shock is too
severe, even large doses of steroids may be ineffective [18].
The loss of adrenal function associated with adrenal atrophy is
almost universal in patients who survived acute adrenal insufﬁ-
ciency [22]. While our patient did not require long-term steroid
therapy, all 10 patients in the literature who recovered via the
corticosteroid replacement therapy were placed on long-term
replacement therapy.
Rao et al. reported their experience in treating several patients
with BAH and developed an algorithm for the diagnosis and
treatment of bilateral massive adrenal hemorrhage [18]. In this
algorithm, they have categorized the progression of the disease into
different levels depending on the severity of cardiopulmonary
status [18]. They emphasized the importance of having high clinical
suspicion for BAH and recommended early intervention with
intravenous corticosteroids.Summary
BAH is a rare complication that can occur with DVT prophylaxis
such as enoxaparin or coumadin. Total joint patients with chemo-
prophylaxis, who present with non-speciﬁc symptoms including
abdominal distress, fever, and anxiety related complaints on post-
operative day 4e10, should not be ignored, and a high index of
clinical suspicion is required to prevent this catastrophic event. CT
scans and hormone assays should be obtained at earliest suspicion
of acute adrenal insufﬁciency, and presumptive steroid treatment
should be initiated while awaiting conﬁrmatory tests.References
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